{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "21",
                "@timestamp": "2021-05-21T14:51:35.000035-04:00",
                "@year": "2021",
                "@month": "05"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "National Science and Technology Development Agency",
                "xocs:funding-agency-acronym": "สวทช",
                "xocs:funding-agency": "National Science and Technology Development Agency",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004192",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-05-16T23:13:02.196478Z",
            "xocs:funding-text": "This study was funded by National Science and Technology Development Agency (NSTDA), Thailand.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Science"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@affiliation-instance-id": "2010758360-2e1017bdf49999b65f89e90d76d36f1c",
                            "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Science, Chulalongkorn University, Bangkok 10330, Thailand",
                            "@dptid": "113044315"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "M.",
                                    "ce:initials": "M.",
                                    "ce:surname": "Tantasawat",
                                    "ce:indexed-name": "Tantasawat M."
                                },
                                "@author-instance-id": "2010758360-1c8d61cd066eb5cf570e93ea301de806",
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Tantasawat",
                                "@auid": "57219944736",
                                "ce:indexed-name": "Tantasawat M."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "C.",
                                    "ce:initials": "C.",
                                    "ce:surname": "Puttilerpong",
                                    "ce:indexed-name": "Puttilerpong C."
                                },
                                "@author-instance-id": "2010758360-e6686d73992e9d1d26d337b19149ab63",
                                "@seq": "2",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Puttilerpong",
                                "@auid": "56144670800",
                                "ce:indexed-name": "Puttilerpong C."
                            },
                            {
                                "ce:given-name": "Panomvana Na",
                                "preferred-name": {
                                    "ce:given-name": "Panomvana Na",
                                    "ce:initials": "P.N.",
                                    "ce:surname": "Ayudhya",
                                    "ce:indexed-name": "Ayudhya P.N."
                                },
                                "@author-instance-id": "2010758360-c436349f45a68e61b794e9db983ec30c",
                                "@seq": "3",
                                "ce:initials": "P.N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ayudhya",
                                "@auid": "57221734655",
                                "ce:indexed-name": "Ayudhya P.N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125771209"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2010758360-5b125d7ae71006cad66bc60fa6a09874",
                            "ce:source-text": "Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125771209"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "P.",
                                "ce:initials": "P.",
                                "ce:surname": "Chantarit",
                                "ce:indexed-name": "Chantarit P."
                            },
                            "@author-instance-id": "2010758360-35fb3e8498f4a0440fa5a709b863ba7b",
                            "@seq": "4",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chantarit",
                            "@auid": "57221720084",
                            "ce:indexed-name": "Chantarit P."
                        }]
                    }
                ],
                "citation-title": "Relationship between Voriconazole Concentration and Invasive Aspergillosis Treatment Outcome: Efficacy and Safety",
                "abstracts": "© 2019. All Rights Reserved.Introduction: This study aimed to determine the association between the voriconazole (VRZ) concentration and clinical outcomes, including both the efficacy and safety in invasive aspergillosis (IA) treatment. Methods: The medical records of adult Thai patients with IA and treated with VRZ at the Ramathibodi Hospital, Thailand, between January 2013 and March 2016 were retrospectively reviewed, and their medical, social, demographic, laboratory data, VRZ dosage regimens and concentrations, and clinical outcome were recorded. The association between the VRZ concentration and clinical outcome was then determined. Results: A total of 81 patients were included in this study. Forty (49.4%) patients were male, with median age of 56.1 years. Sixty of them had hematologic malignancies. Forty-seven patients were diagnosed with probable IA. Median blood sampling time for VRZ level measurement was 11.5 h after the last dose administration on day 9. The median duration of treatment and outcome evaluation was 103 days and 73 days, respectively. Overall success and mortality rate were 76.5% and 14.8%, respectively. In the treatment success group, we found the success rate of around 90% with VRZ trough concentration (Ctr) of 3-4 mg/L. Eleven patients developed liver injuries (LI) and the rate of LI increased significantly with VRZ Ctr of more than 5 mg/L. Conclusion: We recommend VRZ trough concentration of 3-4 mg/L, as at this range the patients responded better to the treatment than at > 5.0 mg/L since it was associated with augmented hepatotoxicity.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Science"},
                            {"$": "Chulalongkorn University"}
                        ]
                    },
                    "person": {
                        "ce:initials": "C.",
                        "ce:surname": "Puttilerpong",
                        "ce:indexed-name": "Puttilerpong C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "clinical outcome",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "hepatotoxicity",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "invasive aspergillosis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "voriconazole",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "IIUM Med. J. Malaysia.",
                    "website": {"ce:e-address": {
                        "$": "https://journals.iium.edu.my/kom/index.php/imjm/index",
                        "@type": "email"
                    }},
                    "@country": "mys",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "27352285",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "18",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "21",
                            "@last": "29"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2019"},
                    "sourcetitle": "IIUM Medical Journal Malaysia",
                    "@srcid": "21101045333",
                    "publicationdate": {
                        "month": "12",
                        "year": "2019",
                        "date-text": "December 2019",
                        "day": "01"
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2700"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was funded by National Science and Technology Development Agency (NSTDA), Thailand.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "National Science and Technology Development Agency"
                        },
                        "grant-agency-id": "1605651"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "11",
                    "@timestamp": "BST 10:58:00",
                    "@year": "2021",
                    "@month": "05"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2010758360",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "931022195",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210436509",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20210321808",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021018185",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "20210178458029",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85099980308",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85099980308",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.31436/IMJM.V18I3.189"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "25",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "1. Kontoyiannis DP, Patterson TF. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions. Clin Infect Dis. 2014;59(Suppl 5):S356-S9.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84986250599",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "S356",
                                    "@last": "S9"
                                }
                            },
                            "ref-text": "1. ;(Suppl 5)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DP",
                                    "@_fa": "true",
                                    "ce:surname": "Kontoyiannis",
                                    "ce:indexed-name": "Kontoyiannis DP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TF.",
                                    "@_fa": "true",
                                    "ce:surname": "Patterson",
                                    "ce:indexed-name": "Patterson TF."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "1. Kontoyiannis DP, Patterson TF. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions. Clin Infect Dis. 2014;59(Suppl 5):S356-S9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "2. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical Infect Dis. 2008;46:1813-21.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "46249126149",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "1813",
                                    "@last": "1821"
                                }
                            },
                            "ref-text": "2",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "De Pauw",
                                        "ce:indexed-name": "De Pauw B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "TJ",
                                        "@_fa": "true",
                                        "ce:surname": "Walsh",
                                        "ce:indexed-name": "Walsh TJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JP",
                                        "@_fa": "true",
                                        "ce:surname": "Donnelly",
                                        "ce:indexed-name": "Donnelly JP"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "DA",
                                        "@_fa": "true",
                                        "ce:surname": "Stevens",
                                        "ce:indexed-name": "Stevens DA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Edwards",
                                        "ce:indexed-name": "Edwards JE"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Calandra",
                                        "ce:indexed-name": "Calandra T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clinical Infect Dis"
                        },
                        "ce:source-text": "2. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical Infect Dis. 2008;46:1813-21."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "3. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of \u201cvoriconazole\u201d Clin Pharmacokinet. 2006;45 (7):649-63R.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic/pharmacodynamic profile of \u201cvoriconazole"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33745632766",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "649",
                                    "@last": "63R"
                                }
                            },
                            "ref-text": "3",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "U",
                                    "@_fa": "true",
                                    "ce:surname": "Theuretzbacher",
                                    "ce:indexed-name": "Theuretzbacher U"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Ihle",
                                    "ce:indexed-name": "Ihle F"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Derendorf",
                                    "ce:indexed-name": "Derendorf H."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "3. Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of \u201cvoriconazole\u201d Clin Pharmacokinet. 2006;45 (7):649-63R."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "4. Lee S, Kim BH, Nam WS, Yoon SH, Cho JY, Shin SG, et al. Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers. J Clin Pharmacol. 2012;52(2): 195-203.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84863011832",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "52",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "195",
                                    "@last": "203"
                                }
                            },
                            "ref-text": "4",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BH",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim BH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WS",
                                        "@_fa": "true",
                                        "ce:surname": "Nam",
                                        "ce:indexed-name": "Nam WS"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Yoon",
                                        "ce:indexed-name": "Yoon SH"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho JY"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "SG",
                                        "@_fa": "true",
                                        "ce:surname": "Shin",
                                        "ce:indexed-name": "Shin SG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Pharmacol"
                        },
                        "ce:source-text": "4. Lee S, Kim BH, Nam WS, Yoon SH, Cho JY, Shin SG, et al. Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers. J Clin Pharmacol. 2012;52(2): 195-203."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "5. Racil Z, Winterova J, Kouba M, Zak P, Malaskova L, Buresova L, et al. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience. Mycoses. 2012;55(6):483-92.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867568482",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "55",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "483",
                                    "@last": "492"
                                }
                            },
                            "ref-text": "5",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Racil",
                                        "ce:indexed-name": "Racil Z"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Winterova",
                                        "ce:indexed-name": "Winterova J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Kouba",
                                        "ce:indexed-name": "Kouba M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Zak",
                                        "ce:indexed-name": "Zak P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Malaskova",
                                        "ce:indexed-name": "Malaskova L"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Buresova",
                                        "ce:indexed-name": "Buresova L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mycoses"
                        },
                        "ce:source-text": "5. Racil Z, Winterova J, Kouba M, Zak P, Malaskova L, Buresova L, et al. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience. Mycoses. 2012;55(6):483-92."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "6. Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, et al. CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole. J Clin Pharmacol. 2009;49(2):196-204.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole"},
                            "refd-itemidlist": {"itemid": {
                                "$": "58849130987",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "196",
                                    "@last": "204"
                                }
                            },
                            "ref-text": "6",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Weiss",
                                        "ce:indexed-name": "Weiss J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MM",
                                        "@_fa": "true",
                                        "ce:surname": "Ten Hoevel",
                                        "ce:indexed-name": "Ten Hoevel MM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Burhenne",
                                        "ce:indexed-name": "Burhenne J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Walter-Sack",
                                        "ce:indexed-name": "Walter-Sack I"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "MM",
                                        "@_fa": "true",
                                        "ce:surname": "Hoffmann",
                                        "ce:indexed-name": "Hoffmann MM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Rengelshausen",
                                        "ce:indexed-name": "Rengelshausen J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Pharmacol"
                        },
                        "ce:source-text": "6. Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, et al. CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole. J Clin Pharmacol. 2009;49(2):196-204."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "7. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clinical Infect Dis. 2002;34:563-71.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0036498964",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "563",
                                    "@last": "571"
                                }
                            },
                            "ref-text": "7",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Denning",
                                        "ce:indexed-name": "Denning DW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Ribaud",
                                        "ce:indexed-name": "Ribaud P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Milpied",
                                        "ce:indexed-name": "Milpied N"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Caillot",
                                        "ce:indexed-name": "Caillot D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Herbrecht",
                                        "ce:indexed-name": "Herbrecht R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Thiel",
                                        "ce:indexed-name": "Thiel E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clinical Infect Dis"
                        },
                        "ce:source-text": "7. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clinical Infect Dis. 2002;34:563-71."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "8. Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46(2):201-11.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "39449117139",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "46",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "201",
                                    "@last": "211"
                                }
                            },
                            "ref-text": "8",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Pascual",
                                    "ce:indexed-name": "Pascual A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Calandra",
                                    "ce:indexed-name": "Calandra T"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Bolay",
                                    "ce:indexed-name": "Bolay S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Buclin",
                                    "ce:indexed-name": "Buclin T"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Bille",
                                    "ce:indexed-name": "Bille J"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Marchetti",
                                    "ce:indexed-name": "Marchetti O."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "8. Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46(2):201-11."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "9. Chu HY, Jain R, Xie H, Pottinger P, Fredricks DN. Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC Infect Dis. 2013;13:105.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84874213705",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "105"}
                            },
                            "ref-text": "9",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HY",
                                    "@_fa": "true",
                                    "ce:surname": "Chu",
                                    "ce:indexed-name": "Chu HY"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Jain",
                                    "ce:indexed-name": "Jain R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Xie",
                                    "ce:indexed-name": "Xie H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Pottinger",
                                    "ce:indexed-name": "Pottinger P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "DN.",
                                    "@_fa": "true",
                                    "ce:surname": "Fredricks",
                                    "ce:indexed-name": "Fredricks DN."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Infect Dis"
                        },
                        "ce:source-text": "9. Chu HY, Jain R, Xie H, Pottinger P, Fredricks DN. Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC Infect Dis. 2013;13:105."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "10. Johnson HJ, Han K, Capitano B, Blisard D, Husain S, Linden PK, et al. Voriconazole pharmacokinetics in liver transplant recipients. Antimicrob Agents Chemother. 2010;54(2):852-9.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Voriconazole pharmacokinetics in liver transplant recipients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "75749128183",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "54",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "852",
                                    "@last": "859"
                                }
                            },
                            "ref-text": "10",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HJ",
                                        "@_fa": "true",
                                        "ce:surname": "Johnson",
                                        "ce:indexed-name": "Johnson HJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Capitano",
                                        "ce:indexed-name": "Capitano B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Blisard",
                                        "ce:indexed-name": "Blisard D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Husain",
                                        "ce:indexed-name": "Husain S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "PK",
                                        "@_fa": "true",
                                        "ce:surname": "Linden",
                                        "ce:indexed-name": "Linden PK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "10. Johnson HJ, Han K, Capitano B, Blisard D, Husain S, Linden PK, et al. Voriconazole pharmacokinetics in liver transplant recipients. Antimicrob Agents Chemother. 2010;54(2):852-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "11. Hassan A, Burhenne J, Riedel KD, Weiss J, Mikus G, Haefeli WE, et al. Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring. Ther Drug Monit. 2011;33:86-93. 2011;33:86-93.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78751642763",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "86",
                                    "@last": "93"
                                }
                            },
                            "ref-text": "11. ;:86 2011;33:-93",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Hassan",
                                        "ce:indexed-name": "Hassan A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Burhenne",
                                        "ce:indexed-name": "Burhenne J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KD",
                                        "@_fa": "true",
                                        "ce:surname": "Riedel",
                                        "ce:indexed-name": "Riedel KD"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Weiss",
                                        "ce:indexed-name": "Weiss J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Mikus",
                                        "ce:indexed-name": "Mikus G"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "WE",
                                        "@_fa": "true",
                                        "ce:surname": "Haefeli",
                                        "ce:indexed-name": "Haefeli WE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "11. Hassan A, Burhenne J, Riedel KD, Weiss J, Mikus G, Haefeli WE, et al. Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring. Ther Drug Monit. 2011;33:86-93. 2011;33:86-93."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "12. Kim SH, Yim DS, Choi SM, Kwon JC, Han S, Lee DG, et al. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Int J Infect Dis. 2011;15(11):e753-8.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80054926702",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "e753",
                                    "@last": "e758"
                                }
                            },
                            "ref-text": "12",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim SH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DS",
                                        "@_fa": "true",
                                        "ce:surname": "Yim",
                                        "ce:indexed-name": "Yim DS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Choi",
                                        "ce:indexed-name": "Choi SM"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Kwon",
                                        "ce:indexed-name": "Kwon JC"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DG",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee DG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Infect Dis"
                        },
                        "ce:source-text": "12. Kim SH, Yim DS, Choi SM, Kwon JC, Han S, Lee DG, et al. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Int J Infect Dis. 2011;15(11):e753-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "13. Miyakis S, J. van Hal S, Ray J, Marriott D. Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect 2010;16:927-33.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Voriconazole concentrations and outcome of invasive fungal infections"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77954630521",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "927",
                                    "@last": "933"
                                }
                            },
                            "ref-text": "S 13",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Miyakis",
                                    "ce:indexed-name": "Miyakis S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "van Hal",
                                    "ce:indexed-name": "van Hal J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ray",
                                    "ce:indexed-name": "Ray J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Marriott",
                                    "ce:indexed-name": "Marriott D."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Microbiol Infect"
                        },
                        "ce:source-text": "13. Miyakis S, J. van Hal S, Ray J, Marriott D. Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect 2010;16:927-33."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "14. Chu HY, Jain R, Xie H, Pottinger P, Fredricks DN. Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC Infect Dis. 2013;13(105).",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84874213705",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {
                                "@volume": "13",
                                "@issue": "105"
                            }},
                            "ref-text": "14",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HY",
                                    "@_fa": "true",
                                    "ce:surname": "Chu",
                                    "ce:indexed-name": "Chu HY"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Jain",
                                    "ce:indexed-name": "Jain R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Xie",
                                    "ce:indexed-name": "Xie H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Pottinger",
                                    "ce:indexed-name": "Pottinger P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "DN.",
                                    "@_fa": "true",
                                    "ce:surname": "Fredricks",
                                    "ce:indexed-name": "Fredricks DN."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Infect Dis"
                        },
                        "ce:source-text": "14. Chu HY, Jain R, Xie H, Pottinger P, Fredricks DN. Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC Infect Dis. 2013;13(105)."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "15. Suzuki Y, Tokimatsu I, Sato Y, Kawasaki K, Sato Y, Goto T, et al. Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity. Clin Chim Acta. 2013;424:119-22.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84879563254",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "424"},
                                "pagerange": {
                                    "@first": "119",
                                    "@last": "122"
                                }
                            },
                            "ref-text": "15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Suzuki",
                                        "ce:indexed-name": "Suzuki Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Tokimatsu",
                                        "ce:indexed-name": "Tokimatsu I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Sato",
                                        "ce:indexed-name": "Sato Y"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kawasaki",
                                        "ce:indexed-name": "Kawasaki K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Sato",
                                        "ce:indexed-name": "Sato Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Goto",
                                        "ce:indexed-name": "Goto T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Chim Acta"
                        },
                        "ce:source-text": "15. Suzuki Y, Tokimatsu I, Sato Y, Kawasaki K, Sato Y, Goto T, et al. Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity. Clin Chim Acta. 2013;424:119-22."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "16. Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs. 2007;67(2):269-98.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Voriconazole: a review of its use in the management of invasive fungal infections"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33847042702",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "67",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "269",
                                    "@last": "298"
                                }
                            },
                            "ref-text": "16",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "LJ",
                                    "@_fa": "true",
                                    "ce:surname": "Scott",
                                    "ce:indexed-name": "Scott LJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Simpson",
                                    "ce:indexed-name": "Simpson D."
                                }
                            ]},
                            "ref-sourcetitle": "Drugs"
                        },
                        "ce:source-text": "16. Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs. 2007;67(2):269-98."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "17. Xu G, Zhu L, Ge T, Liao S, Li N, Qi F. Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation. Int J Antimicrob Agents. 2016;47(6):439-45.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84970015925",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "439",
                                    "@last": "445"
                                }
                            },
                            "ref-text": "17",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Xu",
                                    "ce:indexed-name": "Xu G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Zhu",
                                    "ce:indexed-name": "Zhu L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Ge",
                                    "ce:indexed-name": "Ge T"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Liao",
                                    "ce:indexed-name": "Liao S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li N"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Qi",
                                    "ce:indexed-name": "Qi F."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Antimicrob Agents"
                        },
                        "ce:source-text": "17. Xu G, Zhu L, Ge T, Liao S, Li N, Qi F. Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation. Int J Antimicrob Agents. 2016;47(6):439-45."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "18. Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ. Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother. 2012;56(9):4793-9.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865423887",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "4793",
                                    "@last": "4799"
                                }
                            },
                            "ref-text": "18",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MJ",
                                    "@_fa": "true",
                                    "ce:surname": "Dolton",
                                    "ce:indexed-name": "Dolton MJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JE",
                                    "@_fa": "true",
                                    "ce:surname": "Ray",
                                    "ce:indexed-name": "Ray JE"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SC",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen SC"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Ng",
                                    "ce:indexed-name": "Ng K"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "LG",
                                    "@_fa": "true",
                                    "ce:surname": "Pont",
                                    "ce:indexed-name": "Pont LG"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "AJ.",
                                    "@_fa": "true",
                                    "ce:surname": "McLachlan",
                                    "ce:indexed-name": "McLachlan AJ."
                                }
                            ]},
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "18. Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ. Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother. 2012;56(9):4793-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "19. Mitsani D, Nguyen MH, Shields RK, Toyoda Y, Kwak EJ, Silveira FP, et al. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity. Antimicrob Agents Chemother. 2012;56(5):2371-7.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84860133248",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "2371",
                                    "@last": "2377"
                                }
                            },
                            "ref-text": "19",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Mitsani",
                                        "ce:indexed-name": "Mitsani D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MH",
                                        "@_fa": "true",
                                        "ce:surname": "Nguyen",
                                        "ce:indexed-name": "Nguyen MH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RK",
                                        "@_fa": "true",
                                        "ce:surname": "Shields",
                                        "ce:indexed-name": "Shields RK"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Toyoda",
                                        "ce:indexed-name": "Toyoda Y"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "EJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kwak",
                                        "ce:indexed-name": "Kwak EJ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "FP",
                                        "@_fa": "true",
                                        "ce:surname": "Silveira",
                                        "ce:indexed-name": "Silveira FP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "19. Mitsani D, Nguyen MH, Shields RK, Toyoda Y, Kwak EJ, Silveira FP, et al. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity. Antimicrob Agents Chemother. 2012;56(5):2371-7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "20. Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. Ther Drug Monit. 2018;40(6):663-74.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85056659284",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "663",
                                    "@last": "674"
                                }
                            },
                            "ref-text": "20",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang X"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Ke",
                                    "ce:indexed-name": "Ke X"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Du",
                                    "ce:indexed-name": "Du G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang K"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhai",
                                    "ce:indexed-name": "Zhai S."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "20. Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. Ther Drug Monit. 2018;40(6):663-74."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "21. Dolton MJ, McLachlan AJ. Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity. Int J Antimicrob Agents. 2014;44(3):183-93.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85027943028",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "183",
                                    "@last": "193"
                                }
                            },
                            "ref-text": "21",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MJ",
                                    "@_fa": "true",
                                    "ce:surname": "Dolton",
                                    "ce:indexed-name": "Dolton MJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "AJ.",
                                    "@_fa": "true",
                                    "ce:surname": "McLachlan",
                                    "ce:indexed-name": "McLachlan AJ."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Antimicrob Agents"
                        },
                        "ce:source-text": "21. Dolton MJ, McLachlan AJ. Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity. Int J Antimicrob Agents. 2014;44(3):183-93."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "22. Barbarino JM, Obeng AO, Klein TE, Altman RB. PharmGKB summary: voriconazole pathway, pharmacokinetics. Pharmacogenet Genomics. 2017;27(5):201-9.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "PharmGKB summary: voriconazole pathway, pharmacokinetics"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85014615866",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "201",
                                    "@last": "209"
                                }
                            },
                            "ref-text": "22",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JM",
                                    "@_fa": "true",
                                    "ce:surname": "Barbarino",
                                    "ce:indexed-name": "Barbarino JM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "AO",
                                    "@_fa": "true",
                                    "ce:surname": "Obeng",
                                    "ce:indexed-name": "Obeng AO"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "TE",
                                    "@_fa": "true",
                                    "ce:surname": "Klein",
                                    "ce:indexed-name": "Klein TE"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "RB.",
                                    "@_fa": "true",
                                    "ce:surname": "Altman",
                                    "ce:indexed-name": "Altman RB."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "22. Barbarino JM, Obeng AO, Klein TE, Altman RB. PharmGKB summary: voriconazole pathway, pharmacokinetics. Pharmacogenet Genomics. 2017;27(5):201-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "23. Lamoureux F, Duflot T, Woillard JB, Metsu D, Pereira T, Compagnon P, et al. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections. Int J Antimicrob Agents. 2016;47(2):124-31.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84957434603",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "124",
                                    "@last": "131"
                                }
                            },
                            "ref-text": "23",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Lamoureux",
                                        "ce:indexed-name": "Lamoureux F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Duflot",
                                        "ce:indexed-name": "Duflot T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Woillard",
                                        "ce:indexed-name": "Woillard JB"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Metsu",
                                        "ce:indexed-name": "Metsu D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Pereira",
                                        "ce:indexed-name": "Pereira T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Compagnon",
                                        "ce:indexed-name": "Compagnon P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Antimicrob Agents"
                        },
                        "ce:source-text": "23. Lamoureux F, Duflot T, Woillard JB, Metsu D, Pereira T, Compagnon P, et al. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections. Int J Antimicrob Agents. 2016;47(2):124-31."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "24. Miao Q, Tang JT, van Gelder T, Li YM, Bai YJ, Zou YG, et al. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections. Medicine. 2019;98:3(e14137).",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060142401",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "98"},
                                "pagerange": {"@first": "e14137"}
                            },
                            "ref-text": "24. ;:, 3",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q",
                                        "@_fa": "true",
                                        "ce:surname": "Miao",
                                        "ce:indexed-name": "Miao Q"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JT",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang JT"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "van Gelder",
                                        "ce:indexed-name": "van Gelder T"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "YM",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li YM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "YJ",
                                        "@_fa": "true",
                                        "ce:surname": "Bai",
                                        "ce:indexed-name": "Bai YJ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "YG",
                                        "@_fa": "true",
                                        "ce:surname": "Zou",
                                        "ce:indexed-name": "Zou YG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Medicine"
                        },
                        "ce:source-text": "24. Miao Q, Tang JT, van Gelder T, Li YM, Bai YJ, Zou YG, et al. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections. Medicine. 2019;98:3(e14137)."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "25. Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, et al. Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics. 2017;27(5):190-6.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85015646751",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "190",
                                    "@last": "196"
                                }
                            },
                            "ref-text": "25",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "IS",
                                        "@_fa": "true",
                                        "ce:surname": "Hamadeh",
                                        "ce:indexed-name": "Hamadeh IS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KP",
                                        "@_fa": "true",
                                        "ce:surname": "Klinker",
                                        "ce:indexed-name": "Klinker KP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SJ",
                                        "@_fa": "true",
                                        "ce:surname": "Borgert",
                                        "ce:indexed-name": "Borgert SJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "AI",
                                        "@_fa": "true",
                                        "ce:surname": "Richards",
                                        "ce:indexed-name": "Richards AI"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li W"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Mangal",
                                        "ce:indexed-name": "Mangal N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "25. Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, et al. Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics. 2017;27(5):190-6."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85099980308",
        "dc:description": "Introduction: This study aimed to determine the association between the voriconazole (VRZ) concentration and clinical outcomes, including both the efficacy and safety in invasive aspergillosis (IA) treatment. Methods: The medical records of adult Thai patients with IA and treated with VRZ at the Ramathibodi Hospital, Thailand, between January 2013 and March 2016 were retrospectively reviewed, and their medical, social, demographic, laboratory data, VRZ dosage regimens and concentrations, and clinical outcome were recorded. The association between the VRZ concentration and clinical outcome was then determined. Results: A total of 81 patients were included in this study. Forty (49.4%) patients were male, with median age of 56.1 years. Sixty of them had hematologic malignancies. Forty-seven patients were diagnosed with probable IA. Median blood sampling time for VRZ level measurement was 11.5 h after the last dose administration on day 9. The median duration of treatment and outcome evaluation was 103 days and 73 days, respectively. Overall success and mortality rate were 76.5% and 14.8%, respectively. In the treatment success group, we found the success rate of around 90% with VRZ trough concentration (Ctr) of 3-4 mg/L. Eleven patients developed liver injuries (LI) and the rate of LI increased significantly with VRZ Ctr of more than 5 mg/L. Conclusion: We recommend VRZ trough concentration of 3-4 mg/L, as at this range the patients responded better to the treatment than at > 5.0 mg/L since it was associated with augmented hepatotoxicity.",
        "prism:coverDate": "2019-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85099980308",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "M.",
                "ce:initials": "M.",
                "ce:surname": "Tantasawat",
                "ce:indexed-name": "Tantasawat M."
            },
            "@seq": "1",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tantasawat",
            "@auid": "57219944736",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219944736",
            "ce:indexed-name": "Tantasawat M."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85099980308"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099980308&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85099980308&origin=inward"
            }
        ],
        "source-id": "21101045333",
        "citedby-count": "0",
        "prism:volume": "18",
        "subtype": "ar",
        "dc:title": "Relationship between Voriconazole Concentration and Invasive Aspergillosis Treatment Outcome: Efficacy and Safety",
        "openaccess": "1",
        "prism:issn": "27352285",
        "publishercopyright": "© 2019. All Rights Reserved.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "IIUM Medical Journal Malaysia",
        "prism:pageRange": "21-29",
        "prism:endingPage": "29",
        "openaccessFlag": "true",
        "prism:doi": "10.31436/IMJM.V18I3.189",
        "prism:startingPage": "21",
        "dc:identifier": "SCOPUS_ID:85099980308"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "clinical outcome"
        },
        {
            "@_fa": "true",
            "$": "hepatotoxicity"
        },
        {
            "@_fa": "true",
            "$": "invasive aspergillosis"
        },
        {
            "@_fa": "true",
            "$": "voriconazole"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Medicine (all)",
        "@code": "2700",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "M.",
                "ce:initials": "M.",
                "ce:surname": "Tantasawat",
                "ce:indexed-name": "Tantasawat M."
            },
            "@seq": "1",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tantasawat",
            "@auid": "57219944736",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219944736",
            "ce:indexed-name": "Tantasawat M."
        },
        {
            "preferred-name": {
                "ce:given-name": "C.",
                "ce:initials": "C.",
                "ce:surname": "Puttilerpong",
                "ce:indexed-name": "Puttilerpong C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Puttilerpong",
            "@auid": "56144670800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56144670800",
            "ce:indexed-name": "Puttilerpong C."
        },
        {
            "ce:given-name": "Panomvana Na",
            "preferred-name": {
                "ce:given-name": "Panomvana Na",
                "ce:initials": "P.N.",
                "ce:surname": "Ayudhya",
                "ce:indexed-name": "Ayudhya P.N."
            },
            "@seq": "3",
            "ce:initials": "P.N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Ayudhya",
            "@auid": "57221734655",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221734655",
            "ce:indexed-name": "Ayudhya P.N."
        },
        {
            "preferred-name": {
                "ce:given-name": "P.",
                "ce:initials": "P.",
                "ce:surname": "Chantarit",
                "ce:indexed-name": "Chantarit P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Chantarit",
            "@auid": "57221720084",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221720084",
            "ce:indexed-name": "Chantarit P."
        }
    ]}
}}